Viewing Study NCT07156461


Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2025-12-29 @ 10:58 AM
Study NCT ID: NCT07156461
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-08-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients
Sponsor: Cochlear
Organization:

Study Overview

Official Title: A Pivotal, Interventional, Prospective, Multi-centre Clinical Investigation of Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients With Mixed Hearing Loss, Conductive Hearing Loss or Single-Sided Deafness
Status: RECRUITING
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SONUS
Brief Summary: The goal of this interventional study is to evaluate the clinical performance and sound quality of the Osia 3 Sound Processor and to demonstrate its superiority compared with the Osia 2 Sound Processor in adults with mixed hearing loss, conductive hearing loss, or single-sided deafness.

The main questions this study aims to answer are:

* Do the findings confirm the clinical performance of the Osia 3 Sound Processor?
* Is the Osia 3 Sound Processor superior compared to the Osia 2 Sound Processor?

Participants will:

* Undergo speech performance testing in both quiet and noisy environments
* Provide ratings for a self-reported questionnaire
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: